Nexium
Product Images NDC 16590-625

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Nexium (NDC 16590-625). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nexium 20mg Image (Nexium 20mg)

NEXIUM 20 mg capsule carton label distributed by STAT RX USA LLC, with 15 capsules per package. The label indicates the product is a generic for NEXIUM containing Esomeprazole Magnesium 20 mg (Delayed Release). Manufacturer is AstraZeneca LP, Wilmington, DE. Includes NDC 16590-625-15 and storage instructions, with a caution to take medication with plenty of water.*

FDA Label Image

Figure 1 (Chemiical Structure)

Chemical structure diagram of the active ingredient in NEXIUM, showing the molecular arrangement including methoxy groups, methyl groups, a sulfoxide group, and a magnesium ion with three water molecules.*

FDA Label Image

Figurefour (Nexiumpacket Figurefour)

A line graph showing the percent of patients symptom-free over a 28-day diary period, comparing NEXIUM 40 mg, NEXIUM 20 mg, and placebo. The y-axis represents the percentage of patients symptom-free, and the x-axis represents diary days from 0 to 28. Three separate trend lines correspond to each treatment group, indicating changes in symptom-free percentages over time.*

FDA Label Image

Figureone (Nexiumpacket Figureone)

A line graph showing the percent maintained over six months comparing NEXIUM at doses of 40 mg, 20 mg, and 10 mg versus placebo. The graph includes four lines, with NEXIUM 40 mg maintaining the highest percentage over time, followed by 20 mg, 10 mg, and the placebo group showing the lowest maintenance.*

FDA Label Image

Figurethree (Nexiumpacket Figurethree)

A line graph showing the percentage of patients symptom-free over a 28-day diary period for NEXIUM 40 mg, NEXIUM 20 mg, and placebo groups. The y-axis represents percent of patients symptom-free from 0 to 100%, and the x-axis represents days from 0 to 28. The graph compares symptom relief efficacy between two NEXIUM dosages and placebo over time.*

FDA Label Image

Figuretwo (Nexiumpacket Figuretwo)

A line graph depicting percent maintained over a 6-month period for NEXIUM at 40 mg, 20 mg, 10 mg doses, and placebo. The graph shows higher maintenance percentages for all NEXIUM doses compared to placebo, with data points clearly marked for each month.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.